Bath & Body Works (BBWI) EBITDA (2009 - 2026)

Bath & Body Works (BBWI) has reported EBITDA for 18 consecutive years, with $216.0 million the latest figure, recorded in Q3 2026.

• On a quarterly basis, EBITDA rose 37.58% year-over-year to $216.0 million in Q3 2026; TTM through Aug 2026 was $1.1 billion, a 10.22% decrease from a year earlier, with the FY2026 full-year figure at $1.1 billion, down 11.06% from the prior year.
• EBITDA was $216.0 million for Q3 2026 at Bath & Body Works, down from $599.0 million in the prior quarter.
• Over five years, EBITDA peaked at $879.0 million in Q1 2022 and troughed at $157.0 million in Q3 2025.
• A 5-year average of $341.7 million and a median of $217.0 million in 2024 frame the typical range for EBITDA.
• Across the five-year window, EBITDA plunged 50.61% in 2022 and jumped 37.58% in 2026, its largest moves.
• Over 5 years, EBITDA stood at $202.0 million in 2022, then rose by 9.41% to $221.0 million in 2023, then retreated by 1.36% to $218.0 million in 2024, then slipped by 26.15% to $161.0 million in 2025, then jumped by 34.16% to $216.0 million in 2026.
• The last three EBITDA figures came in at $216.0 million (Q3 2026), $599.0 million (Q1 2026), and $161.0 million (Q4 2025), per Business Quant data.